Le Lézard
Classified in: Health
Subject: MRR

Global Electrosurgery Market Report 2024: Market to Reach $8.99 Billion by 2031 - In-Depth Analysis of Products, Surgeries, and End User Demand Forecasts


DUBLIN, March 25, 2024 /PRNewswire/ -- The "Global Electrosurgery Market by Product (Monopolar, Bipolar Instrument, Generator, Smoke Evacuation System, Electrode), Surgery (Obstetrics, Cardiovascular, General, Orthopedic, Oncology, Neurosurgery, Cosmetic), and End User (Hospital, ASC) - Forecast to 2031" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The global electrosurgery market is projected to reach $8.99 billion by 2031, at a CAGR of 4.8% from 2024 to 2031.

The growth of this market is driven by various factors, including the increasing number of surgical procedures, the growing preference for minimally invasive techniques, the increasing adoption of computer-assisted surgeries, the emergence of medical tourism, particularly in developing nations, the rising incidence of skin, throat, lip, and cervix cancer, and the prevalence of chronic diseases, which is on the rise due to the expanding geriatric population. Additionally, factors such as rising healthcare expenditure and market expansion in emerging economies are expected to create market growth opportunities.

However, the risks associated with electrosurgical procedures and the shortage of surgeons restrain the growth of this market. Additionally, the increasing concerns regarding the release of toxic fumes during electrosurgical procedures pose a significant challenge to the market's growth.

Among the products covered in this report, in 2024, the electrosurgery generators segment is expected to account for the largest share of the electrosurgery market. Electrosurgery generators provide the necessary electrical energy for cutting or coagulating tissues during surgical procedures. Advances in these generators have resulted in enhanced precision, versatility, and efficiency of surgical procedures, consequently reducing trauma and smoke generation. The large market share of this segment is attributed to the high prices of electrosurgery generators compared to other components.

Among the surgery types covered in this report, in 2024, the general surgery segment is expected to account for the largest share of the electrosurgery market. The large market share of this segment can be attributed to several factors, including the rising geriatric population, the preference for minimally invasive procedures, and the advantages of electrosurgery in general procedures. These advantages include faster recovery, shorter healing times, enhanced accuracy in diagnosis and treatment, reduced risk of infections, and decreased postoperative pain compared to traditional surgical techniques.

Among the end users covered in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the electrosurgery market. The large market share of this segment can be attributed to various factors, including the high volume of patient visits, the increasing number of hospitals, the availability of advanced electrosurgery equipment at these facilities, the growing burden of diseases requiring surgical interventions, and the enhanced accessibility to medical practices due to rising healthcare spending. The combination of advanced technology, specialized experience, and comprehensive care make hospitals the preferred choice for medical treatments.

In 2024, North America is expected to account for the largest share of the global electrosurgery market, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. However, Asia-Pacific is projected to register the highest growth rate in the global electrosurgery market during the forecast period. The growth of this regional market is driven by several factors, including increasing healthcare expenditure, a rising geriatric population, a rapid surge in the prevalence of chronic diseases, growth in per capita income, government initiatives aimed at enhancing healthcare infrastructure, and the proliferation of private hospitals.

Key questions answered in the report-

Company Profiles

Scope of the Report:

Electrosurgery Market Assessment - by Product

Note: Other electrosurgical accessories include footswitches, patient return electrodes, mounting carts, cleaners, and holsters.

Electrosurgery Market Assessment - by Surgery Type

Note: Other surgeries include head and neck surgery, dental surgery, ear, nose, and throat (ENT) surgeries, podiatric surgeries, and ophthalmological surgeries.

Electrosurgery Market Assessment - by End User

Electrosurgery Market - by Geography

For more information about this report visit https://www.researchandmarkets.com/r/n7x5dk

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

 

SOURCE Research and Markets


These press releases may also interest you

at 17:00
Zepp Health Corporation ("Zepp" or the "Company") , a global leader in smart wearables and health technology, today announced that it has received a letter from the New York Stock Exchange (the "NYSE") dated April 30, 2024, notifying Zepp that it is...

at 16:55
Revelation Biosciences, Inc. (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three months ended March...

at 16:55
Maple Counseling has partnered with Saban Community Clinic to launch the Saban Partnership Program, aimed at enhancing access to mental healthcare for underserved communities. This initiative includes the introduction of four bilingual Associate...

at 16:35
Bristol Myers Squibb today announced the Phase 3 CheckMate -73L trial did not meet its primary endpoint of progression-free survival (PFS) in unresectable, locally advanced stage III non-small cell lung cancer (NSCLC). CheckMate -73L evaluated...

at 16:35
Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung...

at 16:35
Merrimack Pharmaceuticals, Inc. ("Merrimack" or the "Company") announced that the stockholders at a Special Meeting held today overwhelmingly approved adopting a Plan of Dissolution. Following that announcement, the Board of Directors declared a...



News published on and distributed by: